Blog
About

1
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The coronavirus disease-19 (COVID-19) is caused by the novel severe acute respiratory syndrome coronavirus that was first detected at the end of December 2019. The epidemic has affected various regions of China in different degrees. As the situations evolve, the COVID-19 had been confirmed in many countries, and made a assessment that it can be characterized as a pandemic by the World Health Organization on March 11, 2020. Drugs are the main treatment of COVID-19 patients. Pharmaceutical service offers drug safety ensurance for COVID-19 patients.

          According to COVID-19 prevention and control policy and requirements, combined with series of diagnosis and treatment plans, pharmacists in the first provincial-level COVID-19 diagnosis and treatment unit in Jilin Province in Northeast China have established the management practices of drug supply and pharmaceutical care from four aspects: personnel, drugs supply management, off-label drug use management and pharmaceutical care. During the outbreak, the pharmaceutical department of THJU completed its assigned workload to ensure drug supply. So far, no nosocomial infections and medication errors have occurred, which has stabilized the mood of the staff and boosted the pharmacists' confidence in fighting the epidemic. For the treatment of COVID-19, pharmacists conducted adverse reaction monitoring and participated in the multidisciplinary consultation of COVID-19. Up to now, the COVID-19 patients admitted to THJU have not shown any new serious adverse reactions and been cured finally. The hospital pharmacy department timely adjusted the work mode, and the formed management practices is a powerful guarantee for the prevention and control of the COVID-19 epidemic. This paper summarized the details and practices of drug supply and pharmaceutical services management to provide experience for the people who involving in COVID-19 prevention and contain in other abroad epidemic areas.

          Related collections

          Most cited references 9

          • Record: found
          • Abstract: not found
          • Article: not found

          Improving emergency response collaboration and resource allocation by task network mapping and analysis

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Pharmacological care strategy for antivirals in patients with COVID‐19 complicated by underlying disorders

             R. WANG,  R.R. Wang,  Q Xu (2020)
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Recent insights into 2019-nCoV: a brief but comprehensive review

               Q HAN,  Q Lin,  S Jin (2020)
                Bookmark

                Author and article information

                Contributors
                Journal
                Res Social Adm Pharm
                Res Social Adm Pharm
                Research in Social & Administrative Pharmacy
                Published by Elsevier Inc.
                1551-7411
                1934-8150
                6 April 2020
                6 April 2020
                Affiliations
                Department of Pharmacy, The Third Hospital of Jilin University, Jilin University, Changchun, 130033, Jilin, China
                Author notes
                []Corresponding author. zhukun@ 123456jlu.edu.cn
                Article
                S1551-7411(20)30325-9
                10.1016/j.sapharm.2020.04.001
                7136878
                © 2020 Published by Elsevier Inc.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                Categories
                Article

                Comments

                Comment on this article